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Background
SIV infection of the rhesus macaque is currently the best
animal model available for HIV infection in humans.
However, the regions of SIV that are targeted by T cells,
and the subsequent impact of specific targeting on disease
progression, are insufficiently documented.
Methods
Serially truncated SIVmac239 peptides were used to iden-
tify novel epitopes to the 8 mer level, in an IFN-γ ELISPOT
assay. MHC restriction analysis was performed using
autologous and mismatched B cell lines. Epitope specific
T cell lines were analysed for inhibition of virus replica-
tion in vitro in a virus suppression assay. Polychromatic
flow cytometry was used to identify functional character-
istics of epitope specific cells.
Results
Novel epitope specific CD8 T cell responses were identi-
fied to the 8 mer level in Indian rhesus macaques vacci-
nated with SIVmac239 genes as part of a pre-clinical
vaccine study, using IFN-γ ELISPOT. The functional prop-
erties and differential impact of epitope specific cells on
virus replication will be discussed.
Conclusion
The SIVmac239 proteome remains largely unmapped,
despite this virus being used as a model in the rhesus
macaque for HIV infection. This study provides an insight
into novel SIV epitopes and the impact that targeting may
have on disease progression.
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